The Disability and Reproductive Health during COVID-19 Study Team is researching how the COVID-19 pandemic has impacted the sexual and reproductive health care of women, trans and non-binary people with disabilities in Canada. The study has been reviewed and approved by the University of Toronto Research Ethics Board [#42194] and is funded by the Canadian Institutes of Health Research. “Women, trans, and non-binary people” is used to refer to cisgender women, trans women, trans men, non-binary people who identify as transgender and non-binary people who do not identify as transgender, Indigenous gender-diverse persons and two-spirit people, genderqueer and gender non-conforming people, agender people, bigender people, gender-fluid people, and other gender-diverse people. The research excludes cisgender men. “Disability” comprises a range of disabilities, including those who self-identify as disabled and/or d/Deaf. This definition is inclusive of those who have yet to receive an official diagnosis. We aim to be as inclusive as possible, consistent with our commitment to include those with disabilities who remain invisible and uncounted. We use both identity-first and person-first language (referring to disabled people and people living with disabilities) to recognize different language preferences within disability communities.

Team members: Meredith Evans, Alexandra Rego, Kate Welsh, Sidrah Zafar, Jihan Abbas, Sonia Alimi, Lucy Barker, Anne Berndl, Bonnie Brayton, Janice Du Mont, Yona Lunsky, Amy McPherson, Lesley Pablo, Lesley Tarasoff, Sara Rotenberg, Ashley Vandermorris, Hilary Brown